Induction of interferon alpha from human lymphocytes by autologous, dengue virus-infected monocytes by unknown
INDUCTION OF INTERFERON a FROM HUMAN
LYMPHOCYTES BY AUTOLOGOUS, DENGUE
VIRUS-INFECTED MONOCYTES
BY ICHIRO KURANE AND FRANCIS A. ENNIS
From the Division ofInfectious Diseases, Department ofMedicine, University ofMassachusetts
Medical Center, Worcester, Massachusetts 01605
Monocytes appear to play an important role in dengue virus infection . They
have been identified as cells that support dengue virus replication (1) . Dengue
virus has been recovered from circulating mononuclear cells and lymphoid
organs of dengue virus-infected humans and monkeys (2-4). Cell separation
experiments showed that dengue virus replicates in monocyte fractions, but did
not replicate in the monocyte-depleted fractions (1) . Furthermore, monocytes
containing dengue virus-like structures have been detected in the skin and
kidney of dengue hemorrhagic fever patients (5, 6) . Therefore, dengue virus-
infected monocytes may be active in inducing responses from immune-competent
lymphocytes. It has been hypothesized that immune elimination ofdengue virus-
infected monocytes (DV-monocytes)' may lead to the severe complications of
dengue infection, hemorrhagic manifestations, and shock, which are more com-
monly observed in secondary dengue infections (7) .
In the report we analyzed the in vitro interaction between DV-monocytes and
lymphocytes as a model of primary dengue infection . We used autologous
monocytes and lymphocytes from dengue nonimmune donors . Lymphocytes
produce high titers ofinterferona (IFN-a) after beingexposed to DV-monocytes .
The IFN-a induced was able to inhibit infection of other monocytes by dengue
virus . These results suggest that IFN induction from lymphocytes by DV-
monocytes is an important defense mechanism in primary dengue infections.
Materials and Methods
Human Peripheral Blood Mononuclear Cells (PBMC)
Peripheral blood specimens were obtained from healthy blood bank donors from
Massachusetts who did not have antibodies to dengue virus as determined in a plaque
reduction neutralization test . PBMC were separated by the Ficoll-Hypaque density gra-
dient centrifugation method . Cells were resuspended at the concentration of 1-3 x 10'
cells/ml in RPMI 1640 (Flow Laboratories, Rockville, MD) containing 10% FCS and 10%
dimethylsulfoxide (Fisher Scientific Company, Springfield, NJ) and were cryopreserved
until use .
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Virus and Anti-dengue 2 Antibody
Dengue virus type 2 New Guinea C strain was used for infection of monocytes . The
seed virus was passed in mouse brain and then propagated in mosquito cells (C6/36) . The
virus pool titered 5 X 10' PFU/ml in Vero cells. Ascites fluid from mice hyperimmunized
with dengue virus type 2 was used as anti-dengue 2 antibody . Virus and antibody were
kindly supplied by Dr . Walter E . Brandt of Walter Reed Army Institute of Research,
Bethesda, MD . The titer of this antibody was 1 :1,024 in a plaque-neutralization test .
Hyperimmune ascitic fluid was heated at 56°C for 30 min to destroy complement activity
before use .
Titration ofDengue Virus
The amount of infectious dengue virus was determined by plaque titration in Vero
cells . 0 .1 ml ofserially diluted culture supernatant fluid was placed on Vero cell monolayers
in 24-well plates (Costar, Cambridge, MA) and incubated at 37°C for 2 h. The culture
fluid was then removed, the cells were washed once with RPMI medium, and 1 ml of
overlayer containing 1% agar (Difco Laboratories, Detroit, MI) in MEM, 10% FCS, 0.5%
nonessential amino acids, 0.5% essential vitamins, and 0.3% DEAE-dextran was added .
The plates were cultured at 37°C for 7 d, stained with neutral red, and the number of
plaques was counted.
Isolation ofAdherent Cells
2 X 10' PBMC in 4 ml ofRPMI/10% FCS were cultured in a plastic petri dish with 6-
cm diameter (Falcon Laboratories, Oxnard, CA) at 37°C for 20 h. The dish was rinsed
several times with RPMI/10% FCS until no nonadherent cells were observed under an
inverted microscope . These adherent cells were considered as monocytes . The purity of
monocytes was >90% as determined by a phagocytic assay (8) and by membrane fluores-
cence staining using anti-Mo2 antibody (Coulter Immunology, Hialeah, FL) .
Infection ofHuman Monocytes with Dengue Virus
Dengue virus (5 X 10' PFU/ml) was incubated with 1 :10,000 diluted anti-dengue virus
type 2 antisera at 4 °C for 1 h . Monocytes were infected with dengue virus at a multiplicity
of infection (m.o .i) of 5-10 PFU/cell at 37°C for 2 h on plastic petri dishes . Infected cells
were washed once and cultured at the concentration of 10 6 cells/ml in RPMI/10% FCS
for 48 h unless otherwise stated. The cells were collected and used as IFN-inducer cells .
Treatment ofPBL with Actinomycin D
PBL (4 X 106 cells/ml) were incubated with various concentrations of actinomycin D
(Sigma Chemical Co ., St . Louis, MO) at 0.64 wg/ml at 37°C for 1 h to inhibit the
production of IFN (9) . Cells were washed three times and then were used as producer
cells .
Treatment of DV-monocytes with Glutaraldehyde
Dengue virus-infected and uninfected monocytes were treated with glutaraldehyde as
previously described (10) . Cells were washed three times with PBS, treated with 0.025%
glutaraldehyde in PBS for 10 min at room temperature, washed three times in PBS,
resuspended in RPMI/10% FCS, and used as inducer cells . After treatment, all the cells
were dead, as determined by trypan blue dye-exclusion test .
Treatment of DV-monocytes with Paraformaldehyde
Dengue virus-infected and uninfected monocytes were washed three times with PBS,
treated with 3 .5% paraformaldehyde in PBS for 25 min at room temperature, washed
three times with PBS, resuspended in RPMI/10% FCS, and used as IFN inducer cells .
After treatment,>97% of the cells were dead, as determinedby trypan blue dye-exclusion
test .Induction ofIFN
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5 X 105 PBL were cultured with 10' autologous DV-monocytes in 0.2 ml ofRPMI/10%
FCS at 37 °C for 20 h unless otherwise stated . After cultivation, 0.15 ml of the supernatants
were harvested and examined for IFN activity .
mAbs and Other Reagents
Anti-HLA-DR antibody reacts with monocytes, B cells, and activated T cells (11) .
OKT3 antibody reacts with T cells (12) . Anti-B1 and anti-Leu-12 antibodies react with B
cells (13, 14) . Anti-Leu-11 antibody react with NK cells and neutrophils (15) . OKM1
antibody reacts with monocytes and NK cells (16) . FITC-conjugated anti-HLA-DR, FITC-
conjugated anti-Leu-12, and FITC-conjugated anti-Leu-11, were purchased from Becton
Dickinson Co. (Mountain View, CA) . Anti-OKT3 and anti-OKM 1 were purchased from
Ortho DiagnosticCo . (Raritan, NJ) . FITC-conjugated anti-B1 was purchased from Coulter
Immunology (Hialeah, FL) . FITC-conjugated goat anti-human Ig (IgA + IgG + IgM)
were purchased from Cappel Laboratories (West Chester, PA).
Cell Separation by FRCS
Nonadherent PBL were stained by direct membrane immunofluorescence or by indirect
membrane immunofluorescence. Stained lymphocytes were sorted with a FACS 440
(Becton-Dickinson Co .) as previously reported (17) . Cell viability after sorting exceeded
95% by a trypan blue dye-exclusion test . The purity of each of the sorted populations
was>96% .
Interferon Assays
Bioassay .
￿
Interferon was assessed by a cytopathic effect-reduction assay (18) . Twofold
serial dilutions of supernatant fluids obtained fromPBL exposed to dengue virus-infected
cells were incubated on human fibroblast cells (trisomic for chromosome 21) for 20 h at
37°C and then challenged with vesicular stomatitis virus . An international interferon
standard was included in each assay, and the titers were read after 24 h at 37°C .
Radioimmunoassay.
￿
The IFN content ofsupernatant fluids were also measured in RIA
specific for IFN-a and IFN-? as previously described (10) . Briefly, 6.5-mm-diam etched
polystyrene beads coated with sheep polyclonal antiserum to IFN-a or -'y were incubated
with IFN-containing samples for 2-3 h at 4°C, washed twice, and then incubated with
either radioiodinated 121I-MT4/E4 mAb to IFN-a2 (19) or 12'I-5J mAb to IFN - 'Y (20) for
16 h at 4°C . The beads were rewashed and counted in an LKB gamma counter . RIAs
were calibrated in international units per milliliter using relevant international standards
for HuIFN-a and HuIFN-7 . These mAbs used to detect IFN-a and IFN -'Y are specific for
IFN-a and IFN-'y, respectively .
Results
IFN Inductionfrom PBL by Autologous DV-monocytes .
￿
To dissect the interaction
between PBL and DV-monocytes, we cultured PBL and infected monocytes
together or separately for 20 h, and examined the culture fluids for IFN activity .
Culture fluids of PBL and those of DV-monocytes contained only low titers of
IFN activity . When PBL and DV-monocytes were cultured together, IFN activ-
ities at titers of 200-1,200 U/ml were detected. Only very low titers of IFN
were detected when PBL were cultured with uninfected monocytes (Table I) .
Time-course study showed that IFN activity was detected as early as 4 h after
the beginning of incubation, and the IFN titers reached a maximum level at 16
h . To confirm that the IFN detected was produced by PBL, the PBL were
treated with a 0.64 wg/ml of actinomycin D and then cultured with DV-
monocytes . Pretreatment ofPBL with actinomycin D decreased the titer ofIFN100 2
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TABLE I
Induction ofIFNfrom PBL by Autologous DV-monocytes
Culture Donor :
IFN (U/ml)
5 x 105 PBL were cultured with 10' autologous DV-monocytes for 20 h . Culture
fluids were examined forIFN activity by bioassay .
* The percentages of dengue antigen-positive cells were as follows : donor A, 63% ;
donor B, 57%; donorC, 40%; donor D, 45%; donor E, 58% ; donor F, 49%.
TABLE II
Abrogation ofIFNProduction by Treatment ofPBL
with Actinomycin D
5 x 105 PBL were cultured with 10' inducer cells for 20 h . PBL were
treated with actinomycin D at 0.64 leg/ml as stated in Materials and
Methods .
* Percentage of dengue antigen-positive cells was 58%.
detected from 800 U/ml to 50 U/ml without changing the viability of PBL
(Table II). This result confirmed that the IFN detected in the cultures containing
both PBL and DV-monocytes was produced by PBL .
Requirement for Cell Contact Between PBL and DV-monocytes for IFN Induc-
tion . Culture fluids from DV-monocytes were examined forthe ability to induce
IFN from PBL. When PBL were incubated in theculture fluids ofDV-monocytes
for 20 h, no IFN activity was induced from PBL. These DV-monocytes used in
the experiment, however, induced 200 U/ml ofIFN from PBL when they were
cultured with PBL .
Experiments were also performed using a microporous membrane with 0.4-
Am pores (Costar, Cambridge, MA) to separate the PBL and DV-monocytes .
When PBL and dengue virus-infected cells were mixed and cultured, high titers
of IFN were detected . However, when PBL and DV-monocytes were cultured
in the same well but separated by the membrane, only a low titer of IFN was
detected (Table III) . These results indicate that cell contact between PBL and
DV-monocytes was required for IFN induction .
No RequirementforMHC Compatibility .
￿
To determine whether IFN induction
A B C D E F
PBL + DV-monocytes* 800 400 200 300 1,200 400
PBL + uninfected monocytes 38 50 6 9 <6 <6
PBL 18 50 6 <6 9 <6
DV-monocytes 18 6 18 <6 75 12
Uninfected monocytes <6 <6 <6 <6 <6 <6
PBL Inducer Cells IFN
(U/ml)
Untreated DV-monocytes* 800
Actinomycin D-treated DV-monocytes 50
Untreated Uninfected monocytes 6
Actinomycin D-treated Uninfected monocytes 12
Untreated None 12
Actinomycin D-treated None 6KURANE AND ENNIS
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TABLE III
Requirementfor Cell ContactBetweenPBL and DV-monocytesfor
Induction ofIFN
4x 106PBLand 10 5DV-monocytes were cultured in 1 ml ofRPMI/10%
FCS in thesame well together or separatedby amicroporousmembrane
for 20 h . Culture fluids were examined forIFN activity.
* Percentage of dengue antigen-positive cells was 29%.
TABLE IV
No RequirementforMHC Compatibilityfor IFNInduction
5 x 10 5 PBL from donors 1 and 2 were cultured with 10 4 inducer cells
from donors I and 2 .
* HLA typing of donors; donor 1 : Al, A9, B5, B8, CW6, DR3, DR5;
donor2 : A2, A28, B35, BW55, CW3, CW4, DR4.
$ Percentages of dengue antigen-positive cells in infected monocyte were
as follows : donor 1,43%; donor 2, 53%.
is restricted by MHC, we analyzed IFN induction using the PBL of two donors
who have completely different MHC class I and class II antigens . The DV-
monocytes of each donor induced similar titers of IFN from the PBL of either
donor (Table IV). These results indicate that MHC compatibility is not required
for IFN induction from PBL by DV-monocytes .
IFN Induction by DV-monocytes Treated with Paraformaldehyde or Glutaralde-
hyde . We then examined the ability of paraformaldehyde-treated DV-monocytes
to induce IFN. These cells retained the ability to induce IFN from PBL (Table
V) . Glutaraldehyde-treated, DV-monocytes also induced IFN from PBL (data
not presented) . DV-monocytes treated with paraformaldehyde or glutaraldehyde
PBL Inducer monocytes IFN (U/ml)
Donor 1 * Donor 1
Infected* 200
Uninfected <3
Donor 2
Infected* 200
Uninfected <3
Donor 2* Donor 1
Infected 200
Uninfected <3
Donor 2
Infected 300
Uninfected <3
Culture
Cell contact
between
PBL and IFN(U/ml)
monocytes
PBL + DV-monocytes* Yes 800
PBL+ DV-monocytes No 50
PBL+ uninfected monocytes Yes 12
PBL + uninfected monocytes No 25
PBLalone - 12
DV-monocytes - 12
Uninfected monocytes - <121004 INTERFERON a INDUCTION BY DENGUE-INFECTED MONOCYTES
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TABLE V
Induction ofIFN by Paraformaldehydefixed DV-monocytes
5 x 10'PBLwere cultured for 20 h with 10' inducer cells untreated or
fixed with paraformaldehyde .
* Percentage of dengue antigen-positive cells was 34% .
$ Treatment of monocytes with paraformaldehyde is described in Mate-
rials and Methods .
24
￿
48
11
Time After Infection (Hours)
n
v
0
N
N
(7
N
N
FIGURE 1 .
￿
Correlation between the appearance of dengue antigen (Ag) in DV-monocytes
and IFN-inducing ability . DV-monocytes were fixed with paraformaldehyde at various times
after infection . 5 x 10' PBL were cultured with 10' glutaraldehyde-fixed DV-monocytes for
20 h .
did not produce IFN or infectious dengue virus. These results indicate that
production of IFN is due to stimulation of PBL by dengue virus-infected cells
and does not directly require infectious dengue virus .
Correlation Between Appearance ofDengue Antigen in Infected Monocytes andIFN-
inducing Ability. We then analyzed DV-monocytes at various times after infec-
tion to determine whether there is a correlation between the ability of infected
cells to induce IFN and dengue antigen expression . At various times after
infection, dengue-infected cells were fixed with paraformaldehyde and used as
inducer cells . The infected monocyteswere able to induceIFN 8 hafter infection,
when dengue antigens became detectable. The IFN-inducing ability reached a
maximum level 24 h after infection, when the percentage of antigen-positive
cells also reached a maximum level (Fig. 1) . These results indicate that there is a
Culture
IFN
Untreated
inducer cells
(U/ml)
Paraformalde-
hyde-fixed in-
ducer cells*
PBL+ DV-monocytes* 300 150
PBL + uninfected monocytes <6 <6
PBL <6 <6
DV-monocytes 25 <6
Uninfected monocytes <6 <6KURANE AND ENNIS
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strong correlation between antigen expression and IFN-inducing activity of
dengue-infected cells .
Characterization ofIFNproducing Cells Using mAbs .
￿
PBL that produce IFN in
response to autologous dengue virus-infected monocytes were characterized
using six mAbs ; anti-HLA-DR, OKT3, anti-Leu-12, anti-BI, anti-Leu-12, and
OKM 1 antibodies, and one polyclonal anti-human immunoglobulin (IgA + IgG
+ IgM) antibody . PBL were positively enriched by FACS after reaction with
these antibodies, and then were cultured with DV-monocytes . HLA-DR' and
T3 - cells produced high titers of IFN, while HLA-DR- and T3+ cells produced
very low or undetectable levels of IFN . B cells, characterized as sIg+ , B1+ , and
Leu-12+ produced some IFN, while sIg , B1 - , and Leu-12- cells also produced
IFN . NK cells, characterized as Leu-11+ , produced a similar titer ofIFN as Leu-
11 - cells . M I+ cells, which also includeNK cells, produced a higher titer of IFN
than Ml - cells (Table VI) . These results indicate that IFN producer cells are
heterogeneous, but the predominant IFN-producer cells are HLA-DR' and T3-
cells, and that B and NK cell fractions also include some IFN-producing cells .
Characterization ofProduced IFN.
￿
The IFNs produced were characterized by
RIA using mAbs to IFN-a and IFN-y as detector reagents . The predominant
IFN induced from PBL by DV-monocytes was IFN-a ; in addition, low titers of
IFN-y were also detected in some experiments (Table VII).
Inhibition ofDengue Virus Infection ofMonocytes by Induced IFN.
￿
The effect of
the induced IFN on dengue virus infection of monocytes was examined . PBL
were cultured with DV-monocytes or with uninfected monocytes for 20 h, and
culture fluids were collected and used in the following experiments. Syngeneic
monocytes were incubated in the collected culture fluids for 20 h and then
infected with dengue virus . None (out of 200) of the monocytes treated with
culture fluids from PBL exposed to DV-monocytes, which contained IFN activity
at 800 U/ml, contained dengue virus antigens ; however, 67% (136 of 204) of
the monocytes treated with culture fluids of PBL that had been exposed to
uninfected monocytes contained dengue antigens, and a similar percentage (142
of 212) of monocytes with dengue antigens was observed without addition of
supernatant fluids . A reconstitution experiment was performed in which 400
U/ml of Sendai virus-induced IFN-a (Interferon Sciences, Inc ., New Brunswick,
NJ) was added to monocyte culture 20 h before dengue virus infection . The
percentage of dengue virus-infected cells decreased from 48 to 0.8% . These
results indicate that IFN-a produced by PBL after exposure to DV-monocytes
inhibits infection of monocytes by dengue virus .
Discussion
In this paper we report that DV-monocytes induce high levels ofIFN produc-
tion from autologous lymphocytes of nonimmune donors . It has been reported
that monocytes actively replicate dengue virus (1) ; therefore, in vitro interactions
between DV-monocytes and autologous PBL may reflect interactions that occur
in vivo during dengue virus infection . Narayan et al . have reported IFN induction
from PBL by lentivirus-infected monocytes of goats and sheep (21). Cell mixtures
ofPBL and monocytes were required for induction of IFN . MHC-compatibility
of PBL and monocytes were not required in the lentivirus system (21) . Those1006
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TABLE VI
Characterization ofPBL that Produce IFNin Response to DV-monocytes
PBL were sorted by FACS after reaction with mAbs. 3 X 10 5 sorted PBL were cultured with 10"
inducer cells . Purity ofFACS-sorted cells was>96% . The titers ofIFN produced in theDV-monocyte
cultures without PBL were subtracted from the titers produced in culture that contained PBL
exposed to infected monocytes .
TABLE VII
Characterization by RIA ofIFNInducedfrom PBL by DV-monocytes
IFN (U/ml) determined byRIA
Culture
￿
DonorA
￿
Donor B
￿
DonorG
￿
DonorH
5 X 10 5 PBL were cultured with 10 4 DV-monocytes for 20 h . IFN contained in the culture fluids was
determined by RIA .
Donor
Lymphocytic fractions
IFN (U/ml)
DV-monocytes Uninfected
monocytes
Noinducer cells
A DR+ 388 <6 <6
DR- 38 <6 <6
B DR+ 382 <6 <6
DR- 7 <6 <6
A T3+ 5 <3 <3
T3- 200 <3 <3
B T3+ <6 <6 <6
T3- 275 <6 <6
B sIg+ 14 <3 <3
sIg 200 <3 <3
C B1+ 25 <6 <6
B1- 175 <6 <6
A Leu-12+ 124 <9 <9
Leu-12- 75 <9 <9
B Leu-12+ 150 <6 <6
Leu-12- 100 <6 <6
A Leu-11+ 100 <6 <6
Leu-11- 100 <6 <6
B Leu-11+ 100 6 <6
Leu-11 - 150 <6 <6
A M I+ 262 <6 <6
M 1- 37 <6 <6
B M1+ 200 <6 <6
M1' 75 <6 <6
IFN-a IFN-y IFN-a IFN-y IFN-a IFN--y IFN-a IFN-y
PBL+ DV-monocytes 300 14 1,000 2 150 <2 250 4
PBL+ uninfected monocytes <3 4 <3 5 <3 ND <3 <1
PBL <3 12 <3 <1 9 ND <3 <3
DV-monocytes <3 <1 17 <1 8 ND <3 <3
Uninfected monocytes <3 <1 12 <1 <3 ND <3 <3KURANE AND ENNIS
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results are very consistent with our results using human PBL, monocytes, and
dengue virus, which belongs to the flavivirus group . Narayan et al . attributed
the IFN induction to an IFN-inducing factor that was generated in the lentivirus-
infected monocytes . We have not precisely identified what is responsible for
inducing IFN by the DV-monocytes . However, de novo synthesized viral com-
ponents in the infected cells appear to be necessary, because DV-monocytes
acquired the ability to induce IFN -8 h after infection, when dengue viral
antigens were first detected in the infected cells . Infectious dengue virus pro-
duced by the infected monocytes was not responsible for inducing IFN, because
DV-monocytes treated with paraformaldehyde or glutaraldehyde, which pro-
duced no infectious virus, also induced IFN from PBL . The presence of IFN-
inducing factors secreted from dengue-infected monocytes is not likely, because
IFN induction required cell contact between PBL and DV-monocytes, and the
culture fluids of DV-monocytes did not induce IFN from PBL . Although the
mechanism ofIFN induction by lentivirus-infected goatmonocytesmay be similar
to that by DV-monocytes, the IFN-producer cells and the IFN produced appear
to be different . Narayan et al . characterized the IFN producer cells as T cells,
and the IFN produced was different from the IFN produced by parainfluenza,
which was probably IFN-a, or that induced by Con A, which was probably IFN-
y (21) . In the present experiment, using human DV-monocytes and PBL, the
IFN-producing cells were non-T cells, and the predominant IFN produced is
IFN-a .
Characterization of the PBL that produce IFN after virus infections is a subject
of controversy . The IFN-producing cells have been characterized as NK cells
and large granular lymphocytes using density gradient cell separation techniques
(22) . Recently IFN-producing cells have been characterized using mAbs . Perussia
et al . reported that the predominant IFN-producing cells after infection with
influenza virus, Newcastle Disease virus, and Sendai virus were HLA-DR' and
had no other surface markers (23) . They also stated that NK cells and B cells
produced lower levels ofIFN . In those experiments they added virus to cultured
PBL . In our experiments, we have used DV-monocytes as inducer cells . The
phenotypes of the IFN-producing cells that Perussia et al . reported are very
similar to the phenotypes of the IFN-producing cells in our experiments .
Identification of viral antigens responsible for IFN induction remains to be
elucidated . Ito et al . reported that isolated hemagglutinin-neuraminidase glyco-
proteins of Sendai virus induce IFN from immune lymphocytes (24) . Lebon
reported that mAb to glycoprotein D of herpes simplex virus (HSV) inhibited
the HSV-induced IFN production by PBL (25) . We will perform similar experi-
ments with purified dengue proteins and mAbs to identify the components of
DV-monocytes that induce PBL to produce high levels of IFN .
The role ofIFN in dengue virus infections remains to be elucidated . We have
shown that culture fields obtained from PBL exposed to DV-monocytes com-
pletely inhibited dengue virus infection of monocytes . This result strongly
suggests that the IFN-a produced by PBL in response to DV-monocytes plays a
role in controlling primary dengue infection . In addition to antiviral effects,
IFNs have immunoregulatory effects on NK cells (26), T cells (27), and B cells
(28) . Monocytes may also regulate immune responses to dengue virus by pre-1008
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senting dengue antigens to T cells and by producing IL-1 . Thus, the roles of
IFN and monocytes in recovery from dengue virus infections and in the patho-
genesis ofdengue hemorrhagic fever and dengue shock syndrome are important
subjects for further investigation .
Summary
Human monocytes actively replicate dengue virus . To dissect the primary
immune responses to dengue virus-infected monocytes (DV-monocytes), we
analyzed the interaction between autologous DV-monocytes and the peripheral
blood lymphocytes (PBL) ofdengue nonimmune donors . Interferon (IFN) activ-
ity was detected when PBL were cultured with DV-monocytes . Cell contact
between PBL and DV-monocytes was required for IFN production ; however,
MHC compatibility between PBL and monocytes was not necessary . DV-mono-
cytes fixed with paraformaldehyde or glutaraldehyde, which produced no infec-
tious virus, also induced high levels of IFN from PBL . The ability of DV-
monocytes to induce IFN correlated with the appearance ofdengue antigens .
The PBL that produce IFN were characterized by FACS sorting using mono-
clonal and polyclonal antibodies . HLA-DR' and T3- cells produced high titers
of IFN, while HLA-DR- and T3'' cells produced very low or undetectable levels
of IFN . Moderate titers of IFN were produced by cells contained in B cell
fractions (surface immunoglobulin-positive, B1*, and Leu-12+ ), and cells con-
tained in natural killer cell fractions (Leu-11 + and OKM1+) . Therefore, IFN-
producing cells are heterogeneous, and the predominant producer cells are
characterized as HLA-DR' and non-T lymphocytes . The IFN produced was
characterized by RIA using mAbs to IFN-a and IFN-y . The IFN-a was the
predominant IFN produced ; in addition, a low level of IFN-y was also detected
in some experiments . The culture fluids obtained from PBL exposed to autolo-
gous DV-monocytes, which contained high IFN activity, completely inhibited
dengue virus infection ofmonocytes . These results suggest that IFN-a produced
by PBL exposed to DV-monocytes may play an important role in controlling
primary dengue virus infection .
We thank Dr. Anthony Meager of Division of Viral Products, National Institute for
Biological Standards and Control, United Kingdom, for titration of IFN by RIA, Ms.
Marcia McFadden and Ms . Julie Reitter for FACS sorting, andMs.Judy Gully for editorial
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